Sarepta Therapeutics Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript
Good afternoon, and thank you for joining Guggenheim Genomic Medicines and Rare Disease Conference. I'm Debjit. I'm one of the analysts representing the Guggenheim Therapeutics team. My privilege to host Sarepta's President and CEO; Doug Ingram; and Executive Vice President and CFO, Ian Estepan. Thank you for your time today, gentlemen.
Questions & Answers
And with that, Doug, let me start with a broad question. 5 years since you started at Sarepta. How do you feel about the progress to date? And if there is anything you could have done differently, what's that?
I'm sure there's a lot of things I could have done differently. It's interesting, people who know me will say that I am perennially unsatisfied with everything. I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
